Your browser doesn't support javascript.
loading
Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for High-Risk Acute Lymphoblastic Leukemia.
Srour, Samer A; Milton, Denái R; Bashey, Asad; Karduss-Urueta, Amado; Al Malki, Monzr M; Romee, Rizwan; Solomon, Scott; Nademanee, Auayporn; Brown, Stacey; Slade, Michael; Perez, Rosendo; Rondon, Gabriela; Forman, Stephan J; Champlin, Richard E; Kebriaei, Partow; Ciurea, Stefan O.
Affiliation
  • Srour SA; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Medicine, Baylor College of Medicine, Houston, TX.
  • Milton DR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bashey A; BMT and Acute Leukemia Program at Northside Hospital, Blood and Marrow Transplant Group of Georgia, Atlanta, Georgia.
  • Karduss-Urueta A; Bone Marrow Transplant Program, Instituto de Cancerologia-Clinica Las Americas, Medellin, Colombia.
  • Al Malki MM; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Romee R; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Solomon S; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Nademanee A; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Brown S; BMT and Acute Leukemia Program at Northside Hospital, Blood and Marrow Transplant Group of Georgia, Atlanta, Georgia.
  • Slade M; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri.
  • Perez R; Bone Marrow Transplant Program, Instituto de Cancerologia-Clinica Las Americas, Medellin, Colombia.
  • Rondon G; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Forman SJ; Department of Hematology and HCT, City of Hope National Medical Center, Duarte, California.
  • Champlin RE; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kebriaei P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ciurea SO; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: sciurea@mdanderson.org.
Biol Blood Marrow Transplant ; 23(2): 318-324, 2017 Feb.
Article in En | MEDLINE | ID: mdl-27856368
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Cyclophosphamide / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Immunosuppressive Agents Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2017 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Cyclophosphamide / Precursor Cell Lymphoblastic Leukemia-Lymphoma / Immunosuppressive Agents Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2017 Type: Article